The U.S. Food and Drug Administration has approved a new generic version of the painkiller Relafen. The generic form of the drug, nabumetone, is generally prescribed to treat patients with osteoarthritis and rheumatoid arthritis. Officials with drugmaker Mylan Inc. say the generic formula will be available in both 500 mg and 750 mg tablets.
Read moreBring up the topic of complementary and alternative treatments for multiple sclerosis and you just might start a controversy. However,... Read more »
In my last post, I began our discussion of treating depression with natural supplements with many warnings. I am going to stress some... Read more »
In the next few weeks, children across the U.S. will return to school. When school supplies fill the shelves at the pharmacy, it's... Read more »
For those looking for alternative treatments for anxiety symptoms, especially those of generalized anxiety disorder, one possibility may be... Read more »
Although there are many prescription medications to treat the symptoms of ADHD some parents opt to try some non-prescription remedies... Read more »
Drugmaker Caraco Pharmaceutical Laboratories Ltd. is recalling all lots of Digoxin tablets because the product might vary in size and deliver... Read more »
Drugmaker Johnson & Johnson has issued a recall for lots of the antipsychotic medication Risperdal and its generic equivalent risperidone because... Read more »
The U.S. Food and Drug Administration is reporting that some propafenone HCL tablets are being recalled. Propafenone HCL is a drug used to treat... Read more »
Source: ADAM Encyclopedia
Urine sugar reagent poisoning; Anhydrous Benedict's reagent poisoningHome TreatmentThis type of poisoning requires immediate medical help.Do NOT make... Read more »
From the FDA Consumer Magazine, March-April 2005 by Carol Rados Few people with arthritis would be willing to stop taking a medication that works,... Read more »